ArticleCell death discovery2026

Apatinib inhibits synovial sarcoma progression and angiogenesis via VEGFR2-mediated AKT/FOXO3A and ERK1/2/FOXM1 signaling pathways.

Ruijie Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.